Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Nano Letters|November 4, 2021
Rapid SARS-CoV-2 Nucleic Acid Testing and Pooled Assay by Tetrahedral DNA Nanostructure TransistorXuejun Wang, Derong Kong, Mingquan Guo, et al.Science Bulletin|December 15, 2020
Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2Chenjian Gu, Yang Wu, Huimin Guo, et al.Journal of the American Chemical Society|October 8, 2021
Direct SARS-CoV-2 Nucleic Acid Detection by Y-Shaped DNA Dual-Probe Transistor AssayDerong Kong, Xuejun Wang, Chenjian Gu, et al.Mabs|July 27, 2021
Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoVWen Jiang, Junchao Wang, Shasha Jiao, et al.Genome Medicine|October 15, 2021
Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variantsChunyan Yi, Xiaoyu Sun, Yixiao Lin, et al.Cell Discovery|August 19, 2021
Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infectionJinkai Zang, Yuanfei Zhu, Yu Zhou, et al.JAMA Internal Medicine|August 19, 2020
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, ChinaFan Wu, Mei Liu, Aojie Wang, et al.Biorxiv : the Preprint Server for Biology|January 30, 2023
MANF stimulates autophagy and restores mitochondrial homeostasis to treat toxic proteinopathyYeawon Kim, Chuang Li, Chenjian Gu, et al.Nature Communications|October 14, 2023
MANF stimulates autophagy and restores mitochondrial homeostasis to treat autosomal dominant tubulointerstitial kidney disease in miceYeawon Kim, Chuang Li, Chenjian Gu, et al.Emerging Microbes & Infections|July 26, 2021
A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challengeXiangchuan He, Longfei Ding, Kangli Cao, et al.Pageof 4